In Vitro Fertilization (IVF) Service Market Size, Share, By Type (Fresh IVF Cycle, Thawed IVF Cycle, Donor Egg IVF Cycle), By End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes), and By Region - Trends, Analysis and Forecast till 2034

In Vitro Fertilization (IVF) service market size was valued at USD 1019.3 Million in 2024 and is expected to reach USD 4838.7 Million by 2034, growing at a CAGR of 18.7%

In Vitro Fertilization is a form of reproductive technology applied to help the childless couple conceive. It involves a step-by-step process, beginning with ovarian stimulation. This is a stage wherein the woman will be administered hormone medication to stimulate her ovaries to produce many eggs. These will then be monitored carefully through blood tests and ultrasound to determine the best time to retrieve them. Later on, when eggs have matured, the doctor retrieves them through a minor surgical procedure called egg retrieval. It is usually done under light sedation, with the guidance of a thin needle via the vaginal wall to aspirate the eggs from ovarian follicles. The semen sample is collected from the male partner or a donor simultaneously. The retrieved eggs and the sperm are then mixed in the laboratory dish for fertilization. ICSI—Intracytoplasmic sperm injection: A single sperm can be injected directly into an egg in some cases. After fertilization, the eggs become embryos and are grown in the laboratory for several days. During this time, embryologists monitor their development and quality closely. Only the most viable embryos would be transferred into the woman's uterus. The procedure is called embryo transfer and is performed three to five days after egg retrieval. A thin catheter inserts the embryo(s) into the uterus through the cervix. The remaining good-quality embryos may then be cryopreserved for future use.

After the transfer is done, the woman is prescribed hormonal medications to help her during the early stages of pregnancy. After two weeks, the success is tested by carrying out a pregnancy test. Close monitoring by the doctor happens during the early stages of pregnancy if it occurs before being referred to regular prenatal care. Many of these services for IVF also offer several complementary choices that include genetic testing of embryos, the use of donor eggs or sperm, and surrogacy arrangements. This could run into weeks, or even months, with cycles to arrive at a successful pregnancy. IVF clinics offer one-stop services, including counseling, financial advice, and emotional support. Though IVF has helped many people realize their dream of parenthood, its success rates depend on parameters like age, underlying fertility problems, and other health indices.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Key Drivers of Target Market:

Increasing Infertility Rates:

·       At the global level, infertility rates are on the rise and are attributed to multi-causality. First and foremost, delayed childbearing is due to higher educational qualifications, a career, and becoming economically independent. Besides, lifestyle changes, including obesity and smoking, alcohol consumption, and environmental pollutants, all contribute to the decline in fertility. The emerging trends of underlying medical conditions like endometriosis, polycystic ovary syndrome, and low sperm count have further increased this problem. As a result, the mentioned factors have contributed toward a significant rise in the count of couples looking forward to medical assistance in conceiving.

Growing Adoption of Assisted Reproductive Technologies (ART):

• The growing awareness and acceptance of ARTs, including IVF, as viable solutions to infertility have led to the growth of the market. The rigorous technological advancement in IVF procedures increases the success rate, and more couples are encouraged to go for such treatments. Another reason is the increasing range of services provided by ART, such as egg freezing, sperm donation, and gestational surrogacy, which cater to the diverse needs of patients.

Restrains:

High Cost of IVF Treatments:

• The most significant obstacle to greater market penetration is still the high cost of IVF treatments. The total cost of medicines, consultations, and procedures is high and incurs unaffordable costs for a big section of the population. However, recent trends indicate a change in this scenario. Shared risk financing models, whereby some fertility clinics assume part of the financial burden in return for some share of potential revenue from any successful treatments, have shown promise in making IVF more accessible. Besides this factor, the growing availability of affordable generic fertility medications and the development of cost-effective laboratory techniques also contribute to gradual price reductions in treatment.

Opportunities:

Expansion of IVF Tourism:

• Countries with advanced IVF infrastructure that can offer cost-effective treatments are now becoming medical tourism hubs. This has its area of huge opportunity for the IVF service market by treating international patients at affordable prices with quality care. This is likely to continue with further relaxation in regulations related to cross-border fertility treatment by more countries and an expansion in the global middle-class population. Moreover, developing telemedicine and online consultation further helps gain access for IVF services from centers across the globe, fueling IVF tourism.

The market is segmented based on Type, End-User, and Region.

Type Insights:

• Fresh IVF Cycle: Fresh IVF cycles involve the creation of new eggs and sperm to create embryos that will be transferred immediately. This is the most common category as its success rates remain the highest, and it involves relatively fewer complications than the thawed ones. However, it will still be a backbone to treatments in IVF, and it is resource—and cost-intensive.
• Thawed IVF Cycle: hawed IVF cycles are cycles in which the embryos have already been frozen and are now used for transfer, making it much less invasive to patients and decreasing treatment times. Through this segment, viability has already been boosted to mimic the results of fresh ones by advances in the cryopreservation technique.
• Donor Egg IVF Cycle: The following section uses the donated eggs of another lady, mostly in poor condition, when the patients' eggs are not good. This is especially true for older women or women with specific medical conditions. Demand is on the rise with increasing awareness and social acceptance of egg donation practices.

End-User Insights:

• Fertility Clinics: Key providers of IVF treatments and fertility clinics use all available and up-to-date reproductive care technologies and offer treatment programs created based on individual specifics—a fact of vital importance to many patients. Therefore, fertility clinics are dominating the market due to their specially focused approach.
• Hospitals: These offer overall IVF services in comprehensive packages through their services based on their not being specialized only in IVF. Of course, they provide this benefit for integrated healthcare; the specialization may not be as deep as in fertility clinics. However, they draw patients with conditions looking for treatment in a more general healthcare setting.
• Surgical Centers: These IVF centers focus on the procedural aspect of the procedure, such as egg retrieval and embryo transfer. Often selected for their high efficiency and expertise in minimally invasive procedures, they may need to be more capable of providing the full array of fertility services.
• Clinical Research Institutes: These institutes primarily research and develop new IVF techniques and treatments. A patient may choose this center to use advanced treatments and be part of any clinical trials. This sector is quite significant for the developmental processes of new IVF technologies.

Regional Insights

• North America: The major growth drivers for the North American market include advanced healthcare infrastructure, high awareness, and favorable reimbursement policies. In the United States, the largest market share in the region is attributed to a higher number of fertility clinics and an increasing demand for assisted reproductive technologies.
• Asia Pacific: At the moment, the Asia-Pacific region is growing at an exponential rate for the IVF market. This market is rising due to increasing infertility, medical infrastructure improvements, and increased disposable income. Countries like India and China are significant contributors, and medical tourism will increase the market in the region.
• Europe: Europe has an established market for IVF, and the UK, France, and Germany carry out the highest number of IVF cycles annually. Support from regulation and public funding in some countries is a driving factor in developing these markets.
• Latin America: The IVF market in Latin American countries is growing impressively due to the increasing awareness and ease of access to various fertility treatments and procedures. Brazil and Mexico are emerging as significant markets, with the rise in medical tourism playing a crucial part in market expansion.
• Middle East and Africa: This is an emerging market with increased awareness and accessibility to IVF treatments. However, cultural and religious upbringings and bindings related to limited healthcare infrastructure still seem to exist, which is, again, a major limiting factor to the growth of this market in the region. The main markets in this region are the UAE and South Africa.

In Vitro Fertilization (IVF) Service Market Report Scope:

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study segmented the target market report based on Type, End User, End-User, and Region.

Segmentation:

By Type:

• Fresh IVF Cycle
• Thawed IVF Cycle
• Donor Egg IVF Cycle

By End-User:

• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the in vitro fertilization (IVF) Service Market include Columbia University Fertility Center, Boston IVF, LLC., Shady Grove Fertility Center, Fertility Centers of Illinois, Cleveland Clinic Fertility Center, Reproductive Medicine Associates, Houston Fertility Institute, Mayo Clinic Fertility Center, Pacific Fertility Center, and Colorado Center for Reproductive Medicine.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

• In May 2024, Gameto announced new data demonstrating the clinical-grade manufacturing of an in vitro maturation solution for fertility care. Gameto, a female-led biotechnology company on a mission to reinvent women's healthcare, today announced new research outlining the cellular engineering and manufacturing techniques underlying Fertilo, a novel investigational in vitro maturation (IVM) solution containing engineered ovarian support cells (OSCs) to mature eggs outside of the body. These findings demonstrate that Gameto's quality-by-design strategic product development facilitates OSC-IVM production for clinical and commercial applications.
• In January 2024, ReproTech launched Cryo-Logix, a new entity designed to provide in vitro fertilization clinics with a comprehensive, seamless, end-to-end cryostorage solution. Yo-Logix will function as an independent organization under ReproTech to enable IVF clinics to deliver better patient care from consent to disposition. Cryo-Logix's team will help to ease the administrative constraints that many IVF clinics encounter by handling billing, collections, patient outreach, logistics, and disposition of cryogenic inventory, whether held in the IVF clinic tank or at ReproTech. Cryo-Logix uses clinic EMR data to guarantee that systems communicate more efficiently. Complimentary transport of specimens to and from IVF clinics will also be available to help patients prepare for treatment with no disruptions.

• Columbia University Fertility Center*
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Business Strategies
• Boston IVF, LLC.
• Shady Grove Fertility Center
• Fertility Centers of Illinois
• Cleveland Clinic Fertility Center
• Reproductive Medicine Associates
• Houston Fertility Institute
• Mayo Clinic Fertility Center
• Pacific Fertility Center
• Colorado Center for Reproductive Medicine

“*” marked represents similar segmentation in other categories in the respective section.

Research Objective and Assumption

• Research Objectives
• Assumptions
• Abbreviations

Market Preview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snippet, By Type
  • Market Snippet, By End-User
  • Market Snippet, By Region
• Opportunity Map Analysis

Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Market Trends
• Product Launch
• Merger and Acquisitions
• Impact Analysis
• PEST Analysis
• Porter’s Analysis

Market Segmentation, By Type, Forecast Period up to 10 Years, (USD Mn)

• Overview
  • Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Fresh IVF Cycle
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Thawed IVF Cycle
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Donor Egg IVF Cycle
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By End-User, Forecast Period up to 10 Years, (USD Mn)

• Overview
  • Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Segment Trends
• Fertility Clinics
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Hospitals
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Surgical Centers
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years
• Clinical Research Institutes
  • Overview
  • Market Size and Forecast (USD Mn), and Y-o-Y Growth (%), Forecast Period up to 10 Years

Market Segmentation, By Region, Forecast Period up to 10 Years, (USD Mn)

• Overview
  • Market Value and Forecast (USD Mn), and Share Analysis (%), Forecast Period up to 10 Years
  • Y-o-Y Growth Analysis (%), Forecast Period up to 10 Years
  • Regional Trends
• North America
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • U.S
    • Canada
• Asia Pacific
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • India
    • Japan
    • South Korea
    • China
    • Rest of Asia Pacific
• Europe
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • UK
    • Germany
    • France
    • Russia
    • Italy
    • Rest of Europe
• Latin America
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • Brazil
    • Mexico
    • Rest of Latin America
• Middle East and Africa
  • Market Size and Forecast (USD Mn), By Type, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By End-User, Forecast Period up to 10 Years
  • Market Size and Forecast (USD Mn), By Country, Forecast Period up to 10 Years
    • GCC
    • Israel
    • South Africa
    • Rest of Middle East and Africa

Competitive Landscape

• Heat Map Analysis
• Company Profiles

• Columbia University Fertility Center
• Boston IVF, LLC.
• Shady Grove Fertility Center
• Fertility Centers of Illinois
• Cleveland Clinic Fertility Center
• Reproductive Medicine Associates
• Houston Fertility Institute
• Mayo Clinic Fertility Center
• Pacific Fertility Center
• Colorado Center for Reproductive Medicine

The Last Word

• Future Impact
• About Us
• Contact